Brief Report: Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic caucasians

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 7, 2006, Pages 2792-2795

  Menzaghi, Claudia ^a   Coco, Angelo ^a   Salvemini, Lucia ^a   Thompson, Ryan ^b   De Cosmo, Salvatore ^a   Doria, Alessandro ^b   Trischitta, Vincenzo ^c  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; LIPID; RESISTIN;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FAMILY; FEMALE; GENETIC CORRELATION; GENOTYPE; HERITABILITY; HUMAN; INSULIN RESISTANCE; ITALY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM; WAIST CIRCUMFERENCE; BLOOD; GENETIC POLYMORPHISM; GENETICS;

ADULT; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSULIN RESISTANCE; ITALY; MALE; METABOLIC SYNDROME X; POLYMORPHISM, GENETIC; RESISTIN;

EID: 33745767524     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2715     Document Type: Article

References (20)

1. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S 2002 Resistin, central obesity, and type 2 diabetes. Lancet 359:46-47
2. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA 2004 Regulation of fasted blood glucose by resistin. Science 303:1195-1198
3. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA 2004 An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1:e45
4. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ 2005 Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111:932-939
5. Fujinami A, Obayashi H, Ohta K, Ichimura T, Nishimura M, Matsui H, Kawahara Y, Yamazaki M, Ogata M, Hasegawa G, Nakamura N, Yoshikawa T, Nakano K, Ohta M 2004 Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 339:57-63
6. Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E, Smith SR 2004 Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 89:1844-1848
7. Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M, Pagano GF 2005 Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes Relat Metab Disord 29:1315-1320
8. Hasegawa G, Ohta M, Ichida Y, Obayashi H, Shigeta M, Yamasaki M, Fukui M, Yoshikawa T, Nakamura N 2005 Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol 42:104-109
9. Engert JC, Vohl MC, Williams SM, Lepage P, Loredo-Osti JC, Faith J, Dore C, Renaud Y, Burtt NP, Villeneuve A, Hirschhorn JN, Altshuler D, Groop LC, Despres JP, Gaudet D, Hudson TJ 2002 5′ Flanking variants of resistin are associated with obesity. Diabetes 51:1629-1634
10. Ma X, Warram JH, Trischitta V, Doria 2002 Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:4407-4410
11. Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G 2003 A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52:1611-1618
12. Pizzuti A, Argiolas A, Di Paola R, Baratta R, Rauseo A, Bozzali M, Vigneri R, Dallapiccola B, Trischitta V, Frittitta L 2002 An ATG repeat in the 3′-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab 87:4403-4406
13. Azuma K, Oguchi S, Matsubara Y, Mamizuka T, Murata M, Kikuchi H, Watanabe K, Katsukawa F, Yamazaki H, Shimada A, Saruta T 2004 Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm Metab Res 36:564-570
14. Osawa H, Yamada K, Onuma H, Murakami A, Ochi M, Kawata H, Nishimiya T, Niiya T, Shimizu I, Nishida W, Hashiramoto M, Kanatsuka A, Fujii Y, Ohashi J, Makino H 2004 The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 75:678-686
15. Menzaghi C, Ercolino T, Salvemini L, Coco A, Kim SH, Fini G, Doria A, Trischitta V 2004 Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13. Physiol Genomics 19:170-174
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
17. Almasy L, Blangero J 1998 Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211
18. Comuzzie AG, Rainwater DL, Blangero J, Mahaney MC, VandeBerg JL, MacCluer JW 1997 Shared and unique genetic effects among seven HDL phenotypes. Arterioscler Thromb Vasc Biol 17:859-864
19. Warren DM, Soria JM, Souto JC, Comuzzie A, Fontcuberta J, Blangero J, MacCluer JW, Almasy L 2005 Heritability of hemostasis phenotypes and their correlation with type 2 diabetes status in Mexican Americans. Hum Biol 77:1-15
20. Tejero ME, Cole SA, Cai G, Peebles KW, Freeland-Graves JH, Cox LA, Mahaney MC, Rogers J, VandeBerg JL, Blangero J, Comuzzie AG 2005 Genome-wide scan of resistin mRNA expression in omental adipose tissue of baboons. Int J Obes Relat Metab Disord 29:406-412